InspireMD, Inc. Warrants
NSPRW
NSPRW was delisted on the 7th of July, 2021.
2 hedge funds and large institutions have $5K invested in InspireMD, Inc. Warrants in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
400% more capital invested
Capital invested by funds: $1K → $5K (+$4K)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
33% less funds holding
Funds holding: 3 → 2 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$1.88K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$76 |
NSPRW Hedge Fund Activity: Q4 2020 in Review
2 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in InspireMD, Inc. Warrants (NSPRW) for Q4 2020, worth a combined $5K — up 400% from $1K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of NSPRW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Citadel Advisors, adding an estimated $1.88K. The largest seller was UBS Group, cutting an estimated $76.
- 2 institutional investors held InspireMD, Inc. Warrants (NSPRW) as of Q4 2020, down from 3 in Q3 2020.
- Funds reported $5K of InspireMD, Inc. Warrants stock for Q4 2020, up 400% quarter-over-quarter.
- 0 funds opened new InspireMD, Inc. Warrants positions in Q4 2020 and 1 closed out, a net change of -1 holder.
- The largest InspireMD, Inc. Warrants buyer in Q4 2020 was Citadel Advisors, an estimated $1.88K added.
- The largest InspireMD, Inc. Warrants seller in Q4 2020 was UBS Group, an estimated $76 sold.
Based on aggregated 13F filings for Q4 2020.